Several studies have supported a neuroprotective role of Sig-1R activation by administering an agonist ligand, on neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, ALS, stroke, retinal degeneration, and depression [13,14,22,23,24,25]. This evidence concerns the gene SIGMAR1 and juvenile Huntington disease.